Human herpesvirus-8 antibodies and DNA in HIV-1 infected patients in South Africa
Field | Value | Language |
dc.contributor.author | Alagiozoglou L | en_AU |
dc.contributor.author | Morris L | en_AU |
dc.contributor.author | Bredell H | en_AU |
dc.contributor.author | Martin DJ | en_AU |
dc.contributor.author | Sitas F | en_AU |
dc.date.issued | 2003 | |
dc.date.issued | 2003 | en |
dc.identifier.uri | https://hdl.handle.net/2123/30925 | |
dc.description.abstract | HIV-infected individuals with high levels of IgG antibodies against human herpesvirus-8 (HHV-8) are at increased risk of developing Kaposi's sarcoma. The aim of this study was to measure the association between HHV-8 viraemia and IgG antibody responses (by immunofluorescence) in a group of 201 HIV-infected individuals attending outpatient clinics, 91 in-patients with AIDS and 87 HIV-infected patients admitted with Kaposi's sarcoma. Compared to HIV-infected outpatients, the adjusted odds ratio in relation to Kaposi's sarcoma was 15.4 (95% CI 4.4-54.2) in those with viraemia, 25.1 (95% CI 6.6-95.6) in those with a positive immunofluorescent signal and infinity (lower exact CI 33.6) in those with a high immunofluorescent signal (all P trend < 0.001). Among those without HHV-8 viraemia, 23% were IgG-positive, but only 5.5% had a high immunofluorescent signal. In those who were viraemic, 89.1% were IgG-positive, and 28.2% had a high immunofluorescent signal, suggesting viraemia is associated with high HHV-8 immunofluorescence IgG signal | en_AU |
dc.publisher | Epidemiology and Infection | en_AU |
dc.subject | Adult | en_AU |
dc.subject | genetics | en_AU |
dc.subject | Herpesvirus 8,Human | en_AU |
dc.subject | HIV Infections | en_AU |
dc.subject | Hiv-1 | en_AU |
dc.subject | Humans | en_AU |
dc.subject | Immunoglobulin G | en_AU |
dc.subject | immunology | en_AU |
dc.subject | Male | en_AU |
dc.subject | Odds Ratio | en_AU |
dc.subject | pathogenicity | en_AU |
dc.subject | Africa | en_AU |
dc.subject | Research | en_AU |
dc.subject | Research Support,Non-U.S.Gov't | en_AU |
dc.subject | Risk | en_AU |
dc.subject | Sarcoma,Kaposi | en_AU |
dc.subject | South Africa | en_AU |
dc.subject | Viremia | en_AU |
dc.subject | virology | en_AU |
dc.subject | analysis | en_AU |
dc.subject | Antibodies,Viral | en_AU |
dc.subject | Antibody Formation | en_AU |
dc.subject | complications | en_AU |
dc.subject | Dna,Viral | en_AU |
dc.subject | Female | en_AU |
dc.subject | Fluorescent Antibody Technique | en_AU |
dc.subject.other | Etiology - Resources and Infrastructure | en_AU |
dc.subject.other | Cancer Type - Kaposi's Sarcoma | en_AU |
dc.title | Human herpesvirus-8 antibodies and DNA in HIV-1 infected patients in South Africa | en_AU |
dc.type | Article | en_AU |
Associated file/s
There are no files associated with this item.
Associated collections